Cutaneous Squamous Cell Carcinoma: Clinical Trials

1 trial for Cutaneous Squamous Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Cutaneous Squamous Cell Carcinoma: new trials by email Literature Review of Cutaneous Squamous Cell Carcinoma trials Research Report on Cutaneous Squamous Cell Carcinoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
Cemiplimab, Placebo - Cutaneous Squamous Cell Carcinoma
Phase 3Active not recruitingRegeneron Pharmaceuticals4152019-06-042026-03-27

Interventions

cemiplimab (1)

Sponsors

Regeneron Pharmaceuticals (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Ireland (1)  ·  Italy (1)  ·  Japan (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Russia (1)  ·  Spain (1)  ·  United Kingdom (1)

Results publications

PMID 40454639

NIH funding

2019 (1)